Treating Blood Cancers

By Blood Cancer UnitedScience Medicine Health & Fitness Education Natural Sciences

Treating Blood Cancers episodes

September 15Caring for LGBTQI+ Patients with Cancer
Jason Domogauer, MD, PhD, NYU Perlmutter Cancer Center, New York, NY
Recorded on August 27, 2026

Jason Domogauer, MD, PhD
Director, LGBTQ+ Cancer Care and Research Program, Perlmutter Cancer Center
Assistant Director, Community Outreach and Engagement, Perlmutter Cancer Center
Director, Community Outreach and Engagement, Department of Radiation Oncology;
Assistant Professor, Department of Radiation Oncology
NYU Langone Health
New York, NY
Join us for an insightful conversation with Dr. Jason Domogauer from NYU Perlmutter Cancer Center as we explore the unique challenges and disparities faced by LGBTQI+ individuals across the cancer continuum. Dr. Domogauer discusses the psychosocial, clinical, and communication needs of LGBTQI+ patients with cancer, as well as strategies for delivering inclusive, affirming care. He also shares approaches to fostering welcoming healthcare environments, and highlights resources for both clinicians and patients. Tune in to this thoughtful discussion on advancing equitable, patient-centered cancer care.
Mentioned on this episode:
Cancer Network
Fenway Institute
Kone
Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
36 min
August 28Strengthening Bereavement Care in Oncology
Ramy Sedhom, MD, FASCO, University of Pennsylvania, Plainsboro, NJ
Recorded on August 13, 2026

Ramy Sedhom, MD, FASCO
Associate Professor, Clinical Medicine, Division of Hematology/Oncology
Director, Program in Geriatric Oncology & Supportive Care Innovation and the
Center for Cancer and Aging at the Penn Center for Cancer Care Innovation
University of Pennsylvania
Plainsboro, NJ
In this episode, Dr. Ramy Sedhom from the University of Pennsylvania explores the role of bereavement support in oncology care. He discusses how clinicians can support patients’ families after a loss, recognize when grief may require additional intervention, and incorporate meaningful bereavement practices into routine care. The conversation also examines the impact of patient loss on healthcare professionals and offers practical strategies to reduce clinician moral distress and burnout. Tune in today for this thoughtful conversation!
Mentioned on this episode:
The Journal of Palliative Medicine: Top Ten Tips on Bereavement Care
Man’s Search for Meaning by Viktor E. Frankl
It’s OK That You’re Not OK by Megan Devine
Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
35 min
July 10Waldenström macroglobulinemia: What to Know in Practice
Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN
Recorded on June 23, 2026

Stephen Ansell, MD, PhD
Division Chair, Hematology
Mayo Clinic
Rochester, MN
Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today!
Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
37 min
June 25Mastocytosis: What Clinicians Need to Know
Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY
Recorded on June 2, 2026

Marina Kremyanskaya, MD, PhD
Associate Professor
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
Join Dr. Marina Kremyanskaya from the Icahn School of Medicine at Mount Sinai in this expert discussion on mastocytosis, including an overview of the disease, key signs and symptoms, and current diagnostic criteria with a focus on relevant genetic mutations. She discusses recently approved therapies, emerging treatment approaches, and ongoing clinical trials that are shaping future treatment. The episode also covers approaches to managing complications, addressing treatment-related side effects, and delivering patient-centered care.
Don’t miss this informative episode!
Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
35 min
June 15CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL
Recorded on May 28, 2026

Tara Gregory, MD
President
Colorado Blood Cancer Institute
Denver, CO
Jay Spiegel, MD
Assistant Professor
Division of Transplant and Cellular Therapy
University of Miami Sylvester Comprehensive Cancer Center
Miami, FL
In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma and myeloma. They provide a practical overview of CAR-T, including currently approved indications, importance of early referral, patient selection considerations, and strategies for engaging patients in treatment discussions. The conversation also covers key aspects of toxicity management and post-treatment monitoring, while addressing current limitations of CAR-T therapy and future directions that may further expand its role in patient care. Tune in today for this exciting episode!
Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
This episode is supported by Bristol Myers Squibb, Johnson & Johnson & Legend Biotech, and Kite, a Gilead Company.
43 min
June 02Optimizing HSCT in Blood Cancers
Lori Muffly, MD, MS, Stanford Medicine, Stanford, CA
Recorded on May 12, 2026

Lori Muffly, MD, MS
Professor of Medicine
Division of Blood and Marrow Transplantation & Cellular Therapy
Stanford Medicine
Stanford, CA
In this episode, Dr. Lori Muffly from Stanford Medicine explores how hematopoietic stem cell transplantation (HSCT) continues to play a central role in care, even as cellular therapies evolve. She also discusses recent advances in overall survival and graft versus host disease as well as clinical trials. We also explore barriers to access, the importance of multidisciplinary teams, and resources to support patients and healthcare professionals. Join us for this insightful episode on the important role of HSCT today, and where it’s headed next.
Mentioned on this episode:
www.NMDP.org
www.hematology.org
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
39 min
May 08Clinical Strategies for Supporting Couples, Care Partners, and Families in Oncology Care
Mayra Allen, PhD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA
Recorded on April 23, 2026

Mayra Allen, PhD
Clinical Psychologist, Psycho-Oncology Service
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Join us for an insightful conversation with Mayra Allen, PhD, clinical psychologist at UCSF’s Helen Diller Family Comprehensive Cancer Center, as we explore actionable strategies for supporting couples, caregivers, and families navigating cancer care. This episode examines practical communication approaches, the evolving role of care partners, and ways to help families manage complex situations. The discussion also addresses important yet often overlooked topics, including changes in intimacy, the impact of cultural perspectives across the cancer journey, and resources to support clinicians in delivering whole person oncology care. Tune in to this thoughtful discussion today!
Mentioned on this episode:
Caregivers Action Network (CAN)
Family Caregiver Alliance
Women’s Cancer Resource Center
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
36 min
April 23Driving Progress in AML
David Sallman, MD, Moffitt Cancer Center, Tampa, FL
Recorded on April 9, 2026

David Sallman, MD
Associate Member, Department of Malignant Hematology
Moffitt Cancer Center
Tampa, FL
In this exciting episode, Dr. David Sallman from Moffitt Cancer Center takes a deep dive into acute myeloid leukemia (AML) and the advances transforming patient care. The discussion spans newly approved therapies, including menin inhibitors, as well as promising approaches under investigation in clinical trials, and explores how these innovations are influencing treatment selection, transplantation, and the management of side effects and complications in today’s AML landscape. Tune in today for expert insight into what’s shaping the future of AML care.
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
This episode is supported by Kura Oncology, Inc.
35 min
April 13Redefining Normal: Clinical Insights for Healthcare Professionals Supporting Survivors After Treatment
Matthew Loscalzo, LCSW, APOS Fellow, City of Hope, Duarte, CA
Recorded on March 30, 2026

Matthew Loscalzo, LCSW, APOS Fellow
Founding Executive Director and Professor Emeritus of Supportive Care Medicine
and Professor of Population Sciences
City of Hope
Duarte, CA
In this episode, licensed clinical social worker Matthew Loscalzo explores how survivors and healthcare professionals often define “normal” differently after treatment. He discusses the emotional shifts that impact relationships, work, and future planning, and shares how healthcare professionals can support meaningful conversations and shared decision-making after treatment ends. Tune in to hear practical insights for supporting patients beyond treatment.
Mentioned on this episode:
Loss and Grief: Personal Stories of Doctors and Other Healthcare Professionals by Linda Klein, Matthew Loscalzo (Editor), Marshall Forstein (Editor)
Additional Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
35 min
March 24Optimizing Outcomes in Myeloma
Amy Pierre, MSN, ANP-BC, Flatiron Health and Memorial Sloan Kettering, New York, NY and Peter Voorhees, MD, Levine Cancer Institute, Charlotte, NC
Recorded on March 10, 2026

Amy Pierre, MSN, ANP-BC
Senior Clinical Director, Research Oncology, Flatiron Health
Nurse Practitioner, Memorial Sloan Kettering Cancer Center
New York, NY
Peter Voorhees, MD
Director, Outreach for Hematologic Malignancies, Plasma Cells Disorder
Program, Department of Hematologic Oncology and Blood Disorders
Levine Cancer Institute
Charlotte, NC
Professor, Cancer Medicine
Wake Forest University School of Medicine
Winston-Salem, NC
In this episode, Dr. Peter Voorhees from the Levine Cancer Institute and Amy Pierre, MSN, RN, ANP BC from Flatiron Health and Memorial Sloan Kettering, break down the evolving landscape of myeloma, from early signs and diagnostic criteria to frontline therapy, transplant decisions, and T- cell redirecting therapies. They explore real world challenges in survivorship, treatment toxicity, and disparities in access to advanced therapies, offering practical insights to help care teams support patients more effectively. Tune in for an informative and forward looking discussion shaping the future of myeloma management.
Blood Cancer United Resources:
Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education
Blood Cancer United Resources for Patients
41 min